This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Yu-Che Cheng in Cardiac Injury Treatment
Introduction
Yu-Che Cheng is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of cardiac injury treatment through his innovative research and patents. His work focuses on the mechanisms involved in cardiac injuries and potential therapeutic approaches.
Latest Patents
Yu-Che Cheng holds a patent titled "Microrna let-7 and transforming growth factor beta receptor III axis as target for cardiac injuries." This patent outlines methods for ameliorating cardiac injuries, such as myocardial infarction, by either enhancing the activity of let-7 microRNA or inhibiting the activity of transforming growth factor beta receptor III (TGFBR3). Additionally, the patent provides assay methods for detecting the levels of TGFBR3 and let-7 microRNA in biological samples.
Career Highlights
Yu-Che Cheng is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on improving cardiac health and treatment options for patients suffering from myocardial infarction.
Collaborations
Yu-Che Cheng has collaborated with notable colleagues, including Patrick C H Hsieh and Chen-Yun Chen. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Yu-Che Cheng's innovative work in cardiac injury treatment exemplifies the importance of research and development in medical science. His patent and collaborations highlight his commitment to improving patient outcomes through scientific innovation.